Skip to main content

Role of Stromal Cell-Derived Factor-1 in Endothelial Progenitor Cell-Mediated Vascular Repair and Regeneration

Abstract

Endothelial progenitor cells (EPCs) are immature endothelial cells that participate in vascular repair and postnatal neovascularization and provide a novel and promising therapy for the treatment of vascular disease. Studies in different animal models have shown that EPC mobilization through pharmacological agents and autologous EPC transplantation contribute to restoring blood supply and tissue regeneration after ischemic injury. However, these effects of the progenitor cells in clinical studies exhibit mixed results. The therapeutic efficacy of EPCs is closely associated with the number of the progenitor cells recruited into ischemic regions and their functional abilities and survival in injury tissues. In this review, we discussed the regulating role of stromal cell-derived factor-1 (also known CXCL12, SDF-1) in EPC mobilization, recruitment, homing, vascular repair and neovascularization, and analyzed the underlying machemisms of these functions. Application of SDF-1 to improve the regenerative function of EPCs following vascular injury was also discussed. SDF-1 plays a crucial role in mobilizing EPC from bone marrow into peripheral circulation, recruiting the progenitor cells to target tissue and protecting against cell death under pathological conditions; thus improve EPC regenerative capacity. SDF-1 are crucial for regulating EPC regenerative function, and provide a potential target for improve therapeutic efficacy of the progenitor cells in treatment of vascular disease.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Gutiérrez-Fernández M, Otero-Ortega L, Ramos-Cejudo J, Rodríguez-Frutos B, Fuentes B, Díez-Tejedor E. Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke. Expert Opin Biol Ther. 2015;15:873–81.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Du F, Zhou J, Gong R, Huang X, Pansuria M, Virtue A, et al. Endothelial progenitor cells in atherosclerosis. Front Biosci (Landmark Ed). 2012;17:2327–49.

    Article  CAS  Google Scholar 

  4. 4.

    Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascul Pharmacol. 2007;46:229–37.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Alwjwaj M, Kadir RRA, Bayraktutan U. The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke. Neural Regen Res. 2021;16:1483–9.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Hao D, Fan Y, Xiao W, Liu R, Pivetti C, Walimbe T, et al. Rapid endothelialization of small diameter vascular grafts by a bioactive integrin-binding ligand specifically targeting endothelial progenitor cells and endothelial cells. Acta Biomater. 2020;108:178–93.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Alexandru N, Andrei E, Safciuc F, Dragan E, Balahura AM, Badila E, et al. Intravenous administration of allogenic cell-derived microvesicles of healthy origins defend against atherosclerotic cardiovascular disease development by a direct action on endothelial progenitor cells. Cells. 2020;9:423.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  8. 8.

    Wang J, Chen S, Bihl J. Exosome-mediated transfer of ACE2 (angiotensin-converting enzyme 2) from endothelial progenitor cells promotes survival and function of endothelial cell. Oxid Med Cell Longev. 2020;2020:4213541.

    PubMed  PubMed Central  Google Scholar 

  9. 9.

    Sen T, Aksu T. Endothelial progenitor cell and adhesion molecules determine the quality of the coronary collateral circulation/Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis. Anadolu Kardiyol Derg. 2012;12:447.

    PubMed  Google Scholar 

  10. 10.

    Tsai NW, Hung SH, Huang CR, Chang HW, Chang WN, Lee LH, et al. The association between circulating endothelial progenitor cells and outcome in different subtypes of acute ischemic stroke. Clin Chim Acta. 2014;427:6–10.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Yin Y, Duan J, Guo C, Wei G, Wang Y, Guan Y, et al. Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1alpha/CXCR4 axis. Eur J Pharmacol. 2017;814:274–82.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Kukumberg M, Zaw AM, Wong DHC, Toh CM, Chan BPL, Seet RCS, et al. Characterization and functional assessment of endothelial progenitor cells in ischemic stroke patients. Stem Cell Rev Rep. 2020;17:952–67.

  13. 13.

    Perrotta F, Perna A, Komici K, Nigro E, Mollica M, D’Agnano V, et al. The state of art of regenerative therapy in cardiovascular ischemic disease: biology, signaling pathways, and epigenetics of endothelial progenitor cells. Cells. 2020;9:1886.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  14. 14.

    Lin KC, Chai HT, Chen KH, Sung PH, Chiang JY, Shao PL, et al. Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke-evaluating the impact of therapeutic time points on prognostic outcomes. Stem Cell Res Ther. 2020;11:219.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Stellos K, Gawaz M. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment. Semin Thromb Hemost. 2007;33:159–64.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964–72.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:296–301.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Honold J, Lehmann R, Heeschen C, Walter DH, Assmus B, Sasaki K, et al. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol. 2006;26:2238–43.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009;29:1179–84.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Fan Y, Ye J, Shen F, Zhu Y, Yeghiazarians Y, Zhu W, et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab. 2008;28:90–8.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003;108:3115–21.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Sun J, Li Y, Graziani GM, Filion L, Allan DS. E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1alpha/CXCR4. PLoS One. 2013;8:e60890.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115:186–94.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1–13.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Tervaert JW, Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke. 2008;39:2158–65.

    PubMed  Article  Google Scholar 

  27. 27.

    Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288–93.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Zhao YH, Yuan B, Chen J, Feng DH, Zhao B, Qin C, et al. Endothelial progenitor cells: therapeutic perspective for ischemic stroke. CNS Neurosci Ther. 2013;19:67–75.

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Cheng CC, Chang SJ, Chueh YN, Huang TS, Huang PH, Cheng SM, et al. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genomics. 2013;14:182.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Cheng SM, Chang SJ, Tsai TN, Wu CH, Lin WS, Lin WY, et al. Differential expression of distinct surface markers in early endothelial progenitor cells and monocyte-derived macrophages. Gene Expr. 2013;16:15–24.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005;112:1618–27.

    PubMed  Article  Google Scholar 

  32. 32.

    Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–12.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–12.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Yan X, Cai S, Xiong X, Sun W, Dai X, Chen S, et al. Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation. J Cell Biochem. 2012;113:1437–46.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Rana D, Kumar A, Sharma S. Endothelial progenitor cells as molecular targets in vascular senescence and repair. Curr Stem Cell Res Ther. 2018;13:438–46.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007;21:1141–9.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol. 2008;51:660–8.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Niederseer D, Steidle-Kloc E, Mayr M, Muller EE, Cadamuro J, Patsch W, et al. Effects of a 12-week alpine skiing intervention on endothelial progenitor cells, peripheral arterial tone and endothelial biomarkers in the elderly. Int J Cardiol. 2016;214:343–7.

    PubMed  Article  Google Scholar 

  40. 40.

    Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. 41.

    Rehman J, Li J, Orschell CM, March KL. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164–9.

    Article  Google Scholar 

  42. 42.

    Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007;109:4761–8.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 1995;28:495–500.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD, et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol. 2007;178:8148–57.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111–20.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998;91:100–10.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Kawasawa Y, McKenzie LM, Hill DP, Bono H, Yanagisawa M, RIKEN GER Group, et al. G protein-coupled receptor genes in the FANTOM2 database. Genome Res. 2003;13:1466–77.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Fredriksson R, Lagerstrom MC, Lundin LG, Schiöth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63:1256–72.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  49. 49.

    Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101–9.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998;91:4523–30.

    CAS  PubMed  Article  Google Scholar 

  51. 51.

    Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121:335–48.

    CAS  PubMed  Article  Google Scholar 

  52. 52.

    Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 2012;35:619–28.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  53. 53.

    Messina-Graham S, Broxmeyer H. SDF-1/CXCL12 modulates mitochondrial respiration of immature blood cells in a bi-phasic manner. Blood Cells Mol Dis. 2016;58:13–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A. 1998;95:9448–53.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 2013;495:227–30.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  56. 56.

    Li Y, Chang S, Li W, Tang G, Ma Y, Liu Y, et al. cxcl12-engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice. Stem Cell Res Ther. 2018;9:139.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  57. 57.

    Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:697–703.

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res. 2005;97:1142–51.

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322–8.

    CAS  PubMed  Article  Google Scholar 

  60. 60.

    Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther. 2011;129:97–108.

    CAS  PubMed  Article  Google Scholar 

  61. 61.

    Chen J, Chen S, Zhang C, Zhang L, Xiao X, Das A, et al. Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice. PLoS One. 2012;7:e50105.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–64.

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2007;50:274–80.

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation. 2008;117:206–15.

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Liu ZJ, Tian R, Li Y, Zhang L, Shao H, Yang C, et al. SDF-1alpha-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep. 2016;6:34416.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  66. 66.

    Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, et al. Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke. 2011;42:618–25.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Wu X, Yang S, Duan D, Liu X, Zhang Y, Wang J, Yang C, Jiang S. A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits. J Rheumatol. 2008;35:2241–8.

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973–81.

    CAS  PubMed  Article  Google Scholar 

  69. 69.

    Sen S, McDonald SP, Coates PT, Bonder CS. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond). 2011;120:263–83.

    CAS  Article  Google Scholar 

  70. 70.

    Mitsiadis TA, Barrandon O, Rochat A, Barrandon Y, De Bari C. Stem cell niches in mammals. Exp Cell Res. 2007;313:3377–85.

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006;133:1543–51.

    CAS  PubMed  Article  Google Scholar 

  72. 72.

    Alessandri G, Girelli M, Taccagni G, Colombo A, Nicosia R, Caruso A, et al. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest. 2001;81:875–85.

    CAS  PubMed  Article  Google Scholar 

  73. 73.

    Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, Liu DH, et al. Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol. 2010;37:551–6.

    CAS  PubMed  Article  Google Scholar 

  74. 74.

    Rakkar K, Othman O, Sprigg N, Bath P, Bayraktutan U. Endothelial progenitor cells, potential biomarkers for diagnosis and prognosis of ischemic stroke: protocol for an observational case-control study. Neural Regen Res. 2020;15:1300–7.

    PubMed  PubMed Central  Article  Google Scholar 

  75. 75.

    Liao S, Luo C, Cao B, Hu H, Wang S, Yue H, et al. Endothelial progenitor cells for ischemic stroke: update on basic research and application. Stem Cells Int. 2017;2017:2193432.

    PubMed  PubMed Central  Google Scholar 

  76. 76.

    Zhou WJ, Zhu DL, Yang GY, Zhang Y, Wang HY, Ji KD, et al. Circulating endothelial progenitor cells in Chinese patients with acute stroke. Hypertens Res. 2009;32:306–10.

    CAS  PubMed  Article  Google Scholar 

  77. 77.

    Huang X, Wan M, Yang Q, Ding X, Zhou Z. The stromal cell-derived factor-1 alpha (SDF-1alpha)/cysteine-X-cysteine chemokine receptor 4 (CXCR4) axis: a possible prognostic indicator of acute ischemic stroke. J Int Med Res. 2019;47:1897–907.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776–9.

    CAS  PubMed  Article  Google Scholar 

  79. 79.

    Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213–20.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105:199–206.

    CAS  PubMed  Article  Google Scholar 

  81. 81.

    Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93:1074–81.

    CAS  PubMed  Article  Google Scholar 

  82. 82.

    Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97:3354–60.

    CAS  PubMed  Article  Google Scholar 

  83. 83.

    Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–37.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  84. 84.

    Tilling L, Chowienczyk P, Clapp B. Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. Br J Clin Pharmacol. 2009;68:484–92.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  85. 85.

    Lemoli RM, D’Addio A. Hematopoietic stem cell mobilization. Haematologica. 2008;93:321–4.

    PubMed  Article  Google Scholar 

  86. 86.

    Ishizawa K, Kubo H, Yamada M, Kobayashi S, Suzuki T, Mizuno S, et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun. 2004;324:276–80.

    CAS  PubMed  Article  Google Scholar 

  87. 87.

    Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol. 1999;154:1125–35.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  88. 88.

    Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation. 2008;117:2224–31.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  89. 89.

    De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 2004;104:3472–82.

    PubMed  Article  CAS  Google Scholar 

  90. 90.

    Chang E, Paterno J, Duscher D, Maan ZN, Chen JS, Januszyk M, et al. Exercise induces stromal cell-derived factor-1alpha-mediated release of endothelial progenitor cells with increased vasculogenic function. Plast Reconstr Surg. 2015;135:340e–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  91. 91.

    Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300–5.

    PubMed  Article  Google Scholar 

  92. 92.

    Chen J, Chen S, Chen Y, Zhang C, Wang J, Zhang W, et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. Am J Physiol Endocrinol Metab. 2011;301:E62-71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  93. 93.

    Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–57.

    CAS  PubMed  Article  Google Scholar 

  94. 94.

    Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781–6.

    PubMed  Article  Google Scholar 

  95. 95.

    Kundu N, Domingues CC, Chou C, Ahmadi N, Houston S, Jerry DJ, et al. Use of p53-silenced endothelial progenitor cells to treat ischemia in diabetic peripheral vascular disease. J Am Heart Assoc. 2017;6:e005146.

    PubMed  PubMed Central  Article  Google Scholar 

  96. 96.

    Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007;117:1249–59.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  97. 97.

    Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004;109:2454–61.

    CAS  PubMed  Article  Google Scholar 

  98. 98.

    Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol. 2004;63:84–96.

    CAS  PubMed  Article  Google Scholar 

  99. 99.

    Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci. 2001;938:83–95.

    CAS  PubMed  Article  Google Scholar 

  100. 100.

    Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204–19.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  101. 101.

    Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98:e2-10.

    CAS  PubMed  Article  Google Scholar 

  102. 102.

    Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res. 2008;78:413–21.

    CAS  PubMed  Article  Google Scholar 

  103. 103.

    Li DW, Liu ZQ, Wei J, Liu Y, Hu LS. Contribution of endothelial progenitor cells to neovascularization (review). Int J Mol Med. 2012;30:1000–6.

    CAS  PubMed  Article  Google Scholar 

  104. 104.

    Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203:1221–33.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  105. 105.

    Stellos K, Gawaz M. Platelet interaction with progenitor cells: potential implications for regenerative medicine. Thromb Haemost. 2007;98:922–9.

    CAS  PubMed  Article  Google Scholar 

  106. 106.

    Chen J, López JA. Interactions of platelets with subendothelium and endothelium. Microcirculation. 2005;12:235–46.

    CAS  PubMed  Article  Google Scholar 

  107. 107.

    Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112:1180–8.

    CAS  PubMed  Article  Google Scholar 

  108. 108.

    Oh IY, Yoon CH, Hur J, Kim JH, Kim TY, Lee CS, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood. 2007;110:3891–9.

    CAS  PubMed  Article  Google Scholar 

  109. 109.

    Sreeramkumar V, Leiva M, Stadtmann A, Pitaval C, Ortega-Rodriguez I, Wild MK, et al. Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice. Blood. 2013;122:3993–4001.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  110. 110.

    Liu ZJ, Tian R, An W, Zhuge Y, Li Y, Shao H,et al. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing. Ann Surg. 2010;252:625–34.

    PubMed  Article  Google Scholar 

  111. 111.

    Puri KD, Finger EB, Gaudernack G, Springer TA. Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. J Cell Biol. 1995;131:261–70.

    CAS  PubMed  Article  Google Scholar 

  112. 112.

    Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, El Makhfi N, et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med. 2005;201:63–72.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest. 2006;116:652–62.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  114. 114.

    Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol. 2008;28:644–50.

    CAS  PubMed  Article  Google Scholar 

  115. 115.

    Qin G, Ii M, Silver M, Wecker A, Bord E, Ma H, et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med. 2006;203:153–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  116. 116.

    Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res. 2007;100:204–12.

    CAS  PubMed  Article  Google Scholar 

  117. 117.

    Qiu Y, Zhang C, Zhang G, Tao J. Endothelial progenitor cells in cardiovascular diseases. Aging Med (Milton). 2018;1:204–8.

    Article  Google Scholar 

  118. 118.

    Libby P, Sukhova G, Lee RT, Liao JK. Molecular biology of atherosclerosis. Int J Cardiol. 1997;62:S23-9.

    PubMed  Article  Google Scholar 

  119. 119.

    Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39:733–42.

    CAS  PubMed  Article  Google Scholar 

  120. 120.

    Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation. 2003;108:2511–6.

    PubMed  Article  Google Scholar 

  121. 121.

    Shao H, Tan Y, Eton D, Yang Z, Uberti MG, Li S, et al. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells. 2008;26:1376–84.

    CAS  PubMed  Article  Google Scholar 

  122. 122.

    Su CH, Wu YJ, Chang CY, Tien TY, Tseng SW, Tsai CH, et al. The increase of VEGF secretion from endothelial progenitor cells post ultrasonic VEGF gene delivery enhances the proliferation and migration of endothelial cells. Ultrasound Med Biol. 2013;39:134–45.

    PubMed  Article  Google Scholar 

  123. 123.

    Abe Y, Ozaki Y, Kasuya J, Yamamoto K, Ando J, Sudo R, Ikeda M, Tanishita K. Endothelial progenitor cells promote directional three-dimensional endothelial network formation by secreting vascular endothelial growth factor. PLoS One. 2013;8:e82085.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  124. 124.

    Marti-Fabregas J, Crespo J, Delgado-Mederos R, Martinez-Ramirez S, Pena E, Marin R, et al. Endothelial progenitor cells in acute ischemic stroke. Brain Behav. 2013;3:649–55.

    PubMed  PubMed Central  Article  Google Scholar 

  125. 125.

    Zhao W, Zhao L, Liao J, Luo Y, He L. Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular events. BMC Neurol. 2019;19:22.

    PubMed  PubMed Central  Article  Google Scholar 

  126. 126.

    Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634–7.

    CAS  PubMed  Article  Google Scholar 

  127. 127.

    Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461–8.

    PubMed  Article  Google Scholar 

  128. 128.

    Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2003;42:2073–80.

    PubMed  Article  Google Scholar 

  129. 129.

    Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441–8.

    CAS  PubMed  Article  Google Scholar 

  130. 130.

    Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res. 2007;100:590–7.

    CAS  PubMed  Article  Google Scholar 

  131. 131.

    Zhang Y, Zhang H, Lin S, Chen X, Yao Y, Mao X, et al. SDF-1/CXCR7 Chemokine Signaling is Induced in the Peri-Infarct Regions in Patients with Ischemic Stroke. Aging Dis. 2018;9:287–95.

    PubMed  PubMed Central  Article  Google Scholar 

  132. 132.

    Purcell BP, Elser JA, Mu A, Margulies KB, Burdick JA. Synergistic effects of SDF-1alpha chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials. 2012;33:7849–57.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  133. 133.

    Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. 2007;116:654–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  134. 134.

    Mao L, Huang M, Chen SC, Li YN, Xia YP, He QW, et al. Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke. CNS Neurosci Ther. 2014;20:460–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  135. 135.

    Imanishi T, Tsujioka H, Akasaka T. Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev. 2008;4:275–86.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  136. 136.

    Dai X, Yan X, Zeng J, Chen J, Wang Y, Li Y, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3beta/Fyn-mediated Nrf2 activation in diabetic limb ischemia. Circ Res. 2017;120:e7–23.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  137. 137.

    Lucchesi D, Russo R, Gabriele M, Longo V, Del Prato S, Penno G, et al. Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses. PLoS One. 2014;9:e109298.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  138. 138.

    Shao Y, Luo L, Ren Z, Guo J, Xiao X, Huang J, et al. Smoking-induced inhibition of number and activity of endothelial progenitor cells and nitric oxide in males were reversed by estradiol in premenopausal females. Cardiol Res Pract. 2020;2020:9352518.

    PubMed  PubMed Central  Article  Google Scholar 

  139. 139.

    Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond). 2004;107:273–80.

    CAS  Article  Google Scholar 

  140. 140.

    Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-7.

    CAS  PubMed  Article  Google Scholar 

  141. 141.

    Yu G, Liu P, Shi Y, Li S, Liu Y, Zhu W. Sitagliptin stimulates endothelial progenitor cells to induce endothelialization in aneurysm necks through the SDF-1/CXCR4/NRF2 signaling pathway. Front Endocrinol (Lausanne). 2019;10:823.

    Article  Google Scholar 

  142. 142.

    Zhang XY, Su C, Cao Z, Xu SY, Xia WH, Xie WL, et al. CXCR7 upregulation is required for early endothelial progenitor cell-mediated endothelial repair in patients with hypertension. Hypertension. 2014;63:383–9.

    CAS  PubMed  Article  Google Scholar 

  143. 143.

    Yang Y, Zhou Y, Wang Y, Wei X, Wu L, Wang T, et al. Exendin-4 reverses high glucose-induced endothelial progenitor cell dysfunction via SDF-1beta/CXCR7-AMPK/p38-MAPK/IL-6 axis. Acta Diabetol. 2020;57:1315–26.

    CAS  PubMed  Article  Google Scholar 

  144. 144.

    Cheng M, Qin G. Progenitor cell mobilization and recruitment: SDF-1, CXCR4, alpha4-integrin, and c-kit. Prog Mol Biol Transl Sci. 2012;111:243–64.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  145. 145.

    Stamm C, Liebold A, Steinhoff G, Strunk D. Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell Transplant. 2006;15:S47-56.

    PubMed  Article  Google Scholar 

  146. 146.

    Bianconi V, Sahebkar A, Kovanen P, Bagaglia F, Ricciuti B, Calabro P, et al. Endothelial and cardiac progenitor cells for cardiovascular repair: a controversial paradigm in cell therapy. Pharmacol Ther. 2018;181:156–68.

    CAS  PubMed  Article  Google Scholar 

  147. 147.

    Hill JM, Bartunek J. The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization. Circulation. 2006;113:1926–8.

    PubMed  Article  Google Scholar 

  148. 148.

    Cun Y, Diao B, Zhang Z, Wang G, Yu J, Ma L, et al. Role of the stromal cell derived factor-1 in the biological functions of endothelial progenitor cells and its underlying mechanisms. Exp Ther Med. 2021;21:39.

    CAS  PubMed  Article  Google Scholar 

  149. 149.

    Zhao R, Feng D, Zhuang G, Liu Y, Chi S, Zhang J, et al. Protein kinase CK2 participates in estrogen-mediated endothelial progenitor cell homing to endometriotic lesions through stromal cells in a stromal cell-derived factor-1- CXCR4-dependent manner. Fertil Steril. 2020;113:1067–79.e1065.

  150. 150.

    Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation. 2007;116:1683–92.

    CAS  PubMed  Article  Google Scholar 

  151. 151.

    Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol. 2007;42:792–803.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Min Yao.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical statement

There are no animal experiments carried out for this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, JH., Li, Y., Huang, D. et al. Role of Stromal Cell-Derived Factor-1 in Endothelial Progenitor Cell-Mediated Vascular Repair and Regeneration. Tissue Eng Regen Med 18, 747–758 (2021). https://doi.org/10.1007/s13770-021-00366-9

Download citation

Keywords

  • Endothelial progenitor cells
  • Vascular repair
  • Neovascularization
  • Stromal cell-derived factor-1
  • Vascular disease